Summer 2023
By Colleen Sullivan
The Rally Foundation for Childhood Cancer Research awarded $300,000 in grants to support exploring liquid biopsies to advance precision treatment; uncovering causes of drug resistance in relapsed neuroblastoma; analyzing the proteins that drive medulloblastoma; and testing nanoparticle delivery of targeted therapy in diffuse midline gliomas to lay the groundwork for clinical trials.